Addressing Challenges With Adherence and Persistence to Oral Anticancer Therapies in Patients With Breast Cancer
Event Date:
May 19, 2025Credit Type:
AAPA | ACPE | ANCCCredits:
1.50Fundamentals III: Patient Counseling and Barriers to Care
Content Format:
VideoCredit Type:
AAPA | ANCCCredits:
0.50Fundamentals II: Identifying and Managing AEs of TROP2, HER2, and HER3 ADCs
Content Format:
VideoCredit Type:
AAPA | ANCCCredits:
0.75Effective Management of Adverse Events Associated With ADC Therapy: Expert Answers to Your Questions on Nausea, Alopecia, and Cardiotoxicity
Content Format:
Clinical ThoughtCredit Type:
--Credits:
--Fundamentals I: Understanding and Differentiating ADCs Targeting HER2, HER3, and TROP2 in Solid Tumors
Content Format:
VideoCredit Type:
AAPA | ANCCCredits:
0.50HER2-, HER3-, and TROP2-Targeted ADCs: Latest Progress, Future Possibilities, and Advancing the Therapeutic Relational Connection
Content Format:
SlidesetCredit Type:
--Credits:
--Patient and Provider: What We Can Learn From Each Other
Content Format:
PCE On Demand Live PresentationCredit Type:
AAPA | ANCCCredits:
1.00Resources to Improve the Care of Patients With NSCLC and EGFR Mutations
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.75Expert Think Tank: Lung Cancer Experts Discuss Current Standard of Care and Ongoing Challenges in the Care of Patients With EGFR-Mutated NSCLC
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.25Key Emerging Treatment Strategies for Patients With EGFR-Mutated Advanced NSCLC
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.75Key Ongoing Clinical Trials in HR-Positive/HER2-Negative Early-Stage Breast Cancer
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.50Multidisciplinary Approaches for Evaluating Risk Factors and Preventive Measures for Transgender Individuals
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.50Evolution in Expert Recommendations for CLL Treatment
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Advances in Precision Cancer Care for Community Practitioners: A Focus on NTRK- and RET-Altered Malignancies
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Gynecologic Cancers: Expert Guidance for Community Practice
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Biomarkers in Gastrointestinal Cancer: Applying the Latest Data in Community Practice
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Novel Immunotherapy Approaches Targeting TIGIT: Updates and Perspectives for the Oncology Care Team
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.00Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Social Worker
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Interdisciplinary Hemophilia A Education: Conversation Between Hematologists on the Evolution of Long-term Patient Care
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.50Overview of Risk Assessment and Biomarker Testing to Inform Treatment in HER2-Negative Early Breast Cancer
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.50Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Pharmacist
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.50Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Physical Therapist
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Pediatrician
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.50Choosing Frontline Therapy in Chronic Lymphocytic Leukemia
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Essentials to Deliver Quality Care for Patients With CML: A Team Approach
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.00Expert Guidance on Treatment Advances in Acute Myeloid Leukemia
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Antibody–Drug Conjugates in Lung Cancer Care
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.75Mechanisms of Resistance to EGFR TKI Therapy in Advanced Lung Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Treatment for EGFR-Mutant Lung Cancer After Progression on EGFR TKI
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Role of HER3 in Lung Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: A Pharmacist’s Perspective
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.75Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Medical Oncology Perspective
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.75Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations
Content Format:
MultimediaCredit Type:
ABIM MOC | ACPE | AMA | ANCCCredits:
0.25Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
Content Format:
Podcast EpisodesCredit Type:
AMACredits:
0.50Immunotherapy Approaches for HCC
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Immunotherapy for Advanced HCC: Case Series
Content Format:
Podcast EpisodesCredit Type:
AMACredits:
0.50Workshops With Experts: Advances to Improve Clinical Outcomes for Veterans With Pancreatic Cancer
Content Format:
MultimediaCredit Type:
--Credits:
--Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00The Role of the Immune System and Immune Escape in Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Predictive Biomarkers for Immunotherapy in HNSCC
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25The Importance of Molecular Testing in Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Strategies for Managing Immune-Related Adverse Events in Patients With Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Managing Immune-Related Adverse Events in Head and Neck Cancer
Content Format:
Case ChallengeCredit Type:
ACPE | AMA | ANCCCredits:
0.50Evolving Treatment Options for Thrombocytopenic Patients With MDS
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25An Expert Overview of Immunotherapy for Advanced HCC
Content Format:
Podcast EpisodesCredit Type:
AMACredits:
0.25How I Treat Anemia in MDS
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Management of Higher-Risk MDS
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Novel Therapies for Lower-Risk MDS
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Management Options for NTRK Fusion-positive Patients With Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Rationale for Targeting NTRK Fusions in Head and Neck Cancers
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25NTRK Fusions: Who To Test? When To Test?
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Exploring Future Roles for Immune-Oncology in Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Honing Treatment Strategies in Advanced Prostate Cancer: Latest Evidence to Guide Clinical Practice
Content Format:
VideoCredit Type:
AANP | ACPE | AMACredits:
1.00Immunotherapy for Advanced HCC: Experts Answer Clinician Questions
Content Format:
Podcast EpisodesCredit Type:
AMACredits:
0.25Case Discussion: Newly Diagnosed ES-SCLC
Content Format:
MultimediaCredit Type:
--Credits:
--Hemophilia A Without Inhibitors: Personalizing Therapy With Factor VIII Prophylaxis: Webcast
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Rationale for Using Immunotherapy in the Treatment of ES-SCLC
Content Format:
MultimediaCredit Type:
--Credits:
--Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
Content Format:
MultimediaCredit Type:
--Credits:
--Overview of Therapeutic Options for Relapsed ES-SCLC
Content Format:
MultimediaCredit Type:
--Credits:
--Management of Limited-Stage SCLC
Content Format:
MultimediaCredit Type:
--Credits:
--Immunotherapy for HCC: Current Evidence and Future Directions
Content Format:
VideoCredit Type:
ACPE | AMA | ANCCCredits:
1.00Practical Guidance on Optimizing Management of Follicular Lymphoma
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.25Advances to Improve Clinical Outcomes and Quality of Life for Veterans With Multiple Myeloma
Content Format:
VideoCredit Type:
--Credits:
--How I Manage Patients With NTRK Fusion–Positive Head and Neck Cancer
Content Format:
Case ChallengeCredit Type:
ACPE | AMA | ANCCCredits:
0.50The Current Treatment Landscape in Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
0.25Recent and Emerging Therapies for Follicular Lymphoma
Content Format:
MultimediaCredit Type:
ACPE | AMA | ANCCCredits:
1.00Applying The Results of Practice-Changing Clinical Research To Patient Care in Hepatocellular Carcinoma
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.00Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy
Content Format:
MultimediaCredit Type:
AANP | ACPE | AMACredits:
0.25Cases in CLL: Options for an Older Patient Requiring First-line Therapy
Content Format:
MultimediaCredit Type:
AANP | ACPE | AMACredits:
0.25The Evolution of Immunotherapy in Head and Neck Cancer
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.50Optimizing Multiple Myeloma Care: Expert Guidance for the Practicing Clinician
Content Format:
VideoCredit Type:
ACPE | AMA | ANCCCredits:
1.00The Evolving Role of Cytokine Therapy for Renal Cell Carcinoma: Past, Present, and Future
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
1.00Cases in CLL: Patient Progressing on BR With Subsequent Ibrutinib Intolerance
Content Format:
MultimediaCredit Type:
AANP | ACPE | AMACredits:
0.25Cases in CLL: Fit, Younger Patient Requiring First-line Therapy
Content Format:
MultimediaCredit Type:
AANP | ACPE | AMACredits:
0.25Cases in CLL: Second-Line Therapy Following Chemoimmunotherapy
Content Format:
MultimediaCredit Type:
AANP | ACPE | AMACredits:
0.25How We Are Managing Outpatient Head and Neck Cancer Care During the COVID-19 Pandemic
Content Format:
Text ModuleCredit Type:
ACPE | AMA | ANCCCredits:
0.50Expert Guidance on Optimizing Treatment Strategies for Acute Lymphoblastic Leukemia
Content Format:
Text ModuleCredit Type:
--Credits:
--